Further prospective studies will be needed to clarify the role of LAT1 in guiding BNCT or other therapeutic approaches in HNSCC, particularly in light of the favorable outcomes reported in early-phase BNCT studies. Here, SLC7A5 is linked to head and neck squamous cell carcinoma.